The cause of Sjögren’s syndrome (SjS) due to immunotherapy is not fully understood, but blocking the PD-1/PD-L1 pathway with immune checkpoint inhibitors (ICIs) appears to trigger T-cell activation, leading to infiltration of the salivary gland epithelium (7). The gene discussed is CD274; the disease is Sjogren syndrome.